Girentuximab

INN (International Nonproprietary Name) for RENCAREX®. RENCAREX® is the development name for the therapeutic antibody WX-G250, which is based on the chimeric antibody cG250. The INN for the radiolabelled antibody, which is developed under the name REDECTANE®, is Iodine (124I) girentuximab

Seite gelesen: 468 | Heute: 7
Seite gelesen: 469 | Heute: 2